StockData
Nautilus Biotechnology, Inc. logo

Nautilus Biotechnology, Inc. (NAUT) stock

NAUTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 6/30
$2.36+0.26 (+12.38%)

Close on Nov 17, 2026Market cap $300.60MP/E –Yield –

Nautilus Biotechnology total assets

Total assets on the balance sheet at the end of each period.

Nautilus Biotechnology's total assets was $148.92M at Sep 30, 2026. For fiscal 2025 it was $191.11M, down 21.3% from the year before. The highest annual figure on record is $398.45M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$191.11M-21.3%
FY2024Dec 31, 2024$242.74M-20.6%
FY2023Dec 31, 2023$305.57M-12.7%
FY2022Dec 31, 2022$350.05M-12.1%
FY2021Dec 31, 2021$398.45M+368.7%
FY2020Dec 31, 2020$85.01M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$148.92M-25.9%
Q2 FY2026Jun 30, 2026$163.58M-23.3%
Q1 FY2026Mar 31, 2026$177.78M-21.9%
Q4 FY2025Dec 31, 2025$191.11M-21.3%
Q3 FY2025Sep 30, 2025$200.92M-22.6%
Q2 FY2025Jun 30, 2025$213.19M-21.8%
Q1 FY2025Mar 31, 2025$227.69M-21.1%
Q4 FY2024Dec 31, 2024$242.74M-20.6%
Q3 FY2024Sep 30, 2024$259.70M-18.4%
Q2 FY2024Jun 30, 2024$272.75M-17.5%
Q1 FY2024Mar 31, 2024$288.65M-16.5%
Q4 FY2023Dec 31, 2023$305.57M-12.7%
Q3 FY2023Sep 30, 2023$318.34M-11.4%
Q2 FY2023Jun 30, 2023$330.77M-11.0%
Q1 FY2023Mar 31, 2023$345.88M-10.1%
Q4 FY2022Dec 31, 2022$350.05M-12.1%
Q3 FY2022Sep 30, 2022$359.31M-6.8%
Q2 FY2022Jun 30, 2022$371.71M-5.5%
Q1 FY2022Mar 31, 2022$384.67M+155.6%
Q4 FY2021Dec 31, 2021$398.45M+368.7%
Q3 FY2021Sep 30, 2021$385.35M+155.3%
Q2 FY2021Jun 30, 2021$393.28M+185998.7%
Q1 FY2021Mar 31, 2021$150.50M–
Q4 FY2020Dec 31, 2020$85.01M–
Q3 FY2020Sep 30, 2020$150.95M–
Q2 FY2020Jun 30, 2020$211.33K–

More Nautilus Biotechnology figures

See a number that looks wrong?